Less frequent dosing means less stress for cats and clients

To view this email as a web page, go here.

Message below is a paid advertisement. Content is provided by the sponsor.

Extended flea & tick protection can reduce stress for cats and clients.

Less frequent dosing =
less stress for cats,
clients and your clinic

Extended flea & tick protection for cats

Pet owners already have a lot to remember.
Give them one less thing to forget.

Only BRAVECTO^® (fluralaner) delivers up to 12 weeks* of flea & tick protection in one topical dose.

Good for patients, pet owners and peace of mind

BRAVECTO Topical Solution for Cats is applied about two-thirds less often than monthly treatments.¹ That means protection per dose is nearly 3X longer than monthly treatments.¹ Fewer doses mean fewer potential gaps in protection and less stress for pet owners and cats.

Fast-acting, persistent and long-lasting nose-to-toes flea & tick protection


•	Kills 100% of fleas in 8 hours¹ And keeps killing them for a full 12 weeks^*
•	In a US field study, 1 dose of BRAVECTO reduced fleas by ≥ 99% for 12 weeks^*1
•	Innovative formulation is applied topically, but works systemically¹
•	The Twist'n'Use^™ applicator cap does not need to be removed, making it easy to dose finicky felines

Contact your Merck Animal Health Rep
to order prescription-only BRAVECTO today.

*	BRAVECTO kills fleas and prevents flea infestations for 12 weeks. BRAVECTO Topical Solution for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks.
¹Bravecto Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016.

Important Safety Information:
BRAVECTO Topical Solution for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO has not been shown to be effective for 12 weeks' duration in kittens less than 6 months of age. BRAVECTO is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of BRAVECTO has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving BRAVECTO, even in cats without a history of neurologic abnormalities.

View prescribing information:
BRAVECTO Topical Solution for Cats

If you no longer wish to receive these emails from Merck Animal Health, please unsubscribe here.

Merck Animal Health is committed to protecting your privacy. Information on the collection and use of your personal information may be viewed at www.merck.com/privacy.

This email was sent on behalf of Intervet Inc., Madison, NJ 07940 USA. US/BRV/0318/0045a